Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             34 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia Rahimi, Zohreh
111 C p.
 artikel
2 A concise review on the molecular genetics of acute myeloid leukemia Padmakumar, Devipriya
111 C p.
 artikel
3 Acquired alpha thalassemia associated with myeloid malignancy: A systematic literature review Wang, Chen
111 C p.
 artikel
4 A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML Webster, Jonathan A.
111 C p.
 artikel
5 Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study McBride, Ali
111 C p.
 artikel
6 A systematic review of primary gastric diffuse large B-cell lymphoma: Clinical diagnosis, staging, treatment and prognostic factors Bai, Zhimin
111 C p.
 artikel
7 Autophagic degradation of NOXA underlies stromal cell-mediated resistance to proteasome inhibitors in mantle cell lymphoma Kuroda, Yoshiaki
111 C p.
 artikel
8 Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation – First case series from a single institution Young, Paul E.
111 C p.
 artikel
9 Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI Ma, Chen-En
111 C p.
 artikel
10 Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma Wang, Jinni
111 C p.
 artikel
11 Editorial Board
111 C p.
 artikel
12 Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias Kota, Vamsi
111 C p.
 artikel
13 Hematogones with light chain restriction: A potential diagnostic pitfall when using flow cytometry analysis to assess bone marrow specimens El Hussein, Siba
111 C p.
 artikel
14 Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry Plesa, Adriana
111 C p.
 artikel
15 Mutational profile and relative telomere length in Chronic Myelomonocytic Leukemia subgroups according to the 2016 World Health Organization classification Martinez-Verbo, Laura
111 C p.
 artikel
16 MYC overexpression is associated with an early disease progression from MDS to AML Gajzer, David
111 C p.
 artikel
17 NFYB potentiates STK33 activation to promote cisplatin resistance in diffuse large B-cell lymphoma Feng, Lili
111 C p.
 artikel
18 No margin for non-adherence: Probabilistic kaplan-meier modeling of imatinib non-adherence and treatment response in CML (ADAGIO study) Obeng-Kusi, Mavis
111 C p.
 artikel
19 Not all bad: Drug-induced interstitial pneumonia in DLBCL patients is potentially fatal but could be linked to better survival Wei, Wen
111 C p.
 artikel
20 Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series Bayrak, Ayse Gul
111 C p.
 artikel
21 Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment Gowin, Krisstina
111 C p.
 artikel
22 Pre-existing cytopenia heralding de novo acute myeloid leukemia: Uncommon presentation of NPM1-mutated AML in a single-center study Galassi, Laura
111 C p.
 artikel
23 Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis Villani, Laura
111 C p.
 artikel
24 Prognostic significance of ATM mutations in chronic lymphocytic leukemia: A meta-analysis Baghaei Vaji, Farnaz
111 C p.
 artikel
25 Proposal and clinical application of molecular genetic risk scoring system, “MRplus”, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre Gupta, Sanjeev Kumar
111 C p.
 artikel
26 Radiation-Free myeloablative allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia: A comparison of outcomes between patients with and without central nervous system involvement Esfandbod, Mohsen
111 C p.
 artikel
27 Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study Kannan, Kavya K.
111 C p.
 artikel
28 Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion Borsky, Marek
111 C p.
 artikel
29 RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia Chow, Signy
111 C p.
 artikel
30 Serum metabolomic profiling based on GC/MS helped to discriminate Diffuse Large B-cell Lymphoma patients with different prognosis Mi, Mi
111 C p.
 artikel
31 Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study Tao, Yunxia
111 C p.
 artikel
32 Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial Luger, Selina M.
111 C p.
 artikel
33 Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients Park, Hyunkyung
111 C p.
 artikel
34 Venetoclax in combination with low dose Cytarabine and Actinomycin D for primary refractory acute myeloid leukemia patients failing intensive chemotherapy Daraskevicius, Justinas
111 C p.
 artikel
                             34 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland